IRIS
GALETTI, Maricla
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.834
NA - Nord America 2.651
AS - Asia 1.281
AF - Africa 50
SA - Sud America 27
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.846
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.618
IT - Italia 815
CN - Cina 735
FI - Finlandia 517
IE - Irlanda 489
SE - Svezia 419
SG - Singapore 378
DE - Germania 199
UA - Ucraina 128
TR - Turchia 79
FR - Francia 67
IN - India 55
GB - Regno Unito 54
CI - Costa d'Avorio 48
AT - Austria 40
BE - Belgio 38
CA - Canada 29
BR - Brasile 22
NL - Olanda 15
CZ - Repubblica Ceca 10
HK - Hong Kong 10
VN - Vietnam 10
ES - Italia 8
IR - Iran 6
LT - Lituania 6
CH - Svizzera 5
HU - Ungheria 5
AR - Argentina 4
MX - Messico 4
PL - Polonia 4
RU - Federazione Russa 4
PT - Portogallo 3
RO - Romania 3
NZ - Nuova Zelanda 2
PK - Pakistan 2
AZ - Azerbaigian 1
DK - Danimarca 1
EC - Ecuador 1
EG - Egitto 1
EU - Europa 1
JO - Giordania 1
JP - Giappone 1
KR - Corea 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MA - Marocco 1
NO - Norvegia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
Totale 6.846
Salva come PNG Salva come JPEG
Città #
Dublin 489
Chandler 474
Parma 300
Singapore 289
Ann Arbor 273
Santa Clara 170
Jacksonville 158
Beijing 153
Dearborn 153
Ashburn 137
Boardman 137
Shanghai 112
Nanjing 97
Princeton 74
Izmir 72
New York 63
Chicago 59
Bremen 57
Milan 56
San Mateo 51
Abidjan 48
Wilmington 47
Helsinki 39
Shenyang 39
Vienna 39
Nanchang 35
Kunming 30
Des Moines 28
Marseille 28
Hefei 27
Modena 27
Jinan 26
Los Angeles 23
Rome 23
Brussels 21
Hebei 21
Seattle 21
Tianjin 21
Munich 17
Toronto 17
Bologna 16
Redmond 15
Jiaxing 14
London 14
Changsha 13
Dallas 13
Norwalk 13
Pune 13
Frankfurt am Main 12
Houston 12
Leawood 12
Wayne 12
Woodbridge 12
Guangzhou 11
Dong Ket 10
Hong Kong 10
Reggio Emilia 10
Verona 10
Zhengzhou 10
Amsterdam 9
Augusta 8
Fremont 8
Ningbo 8
Binche 7
Düsseldorf 7
Genoa 7
Haikou 7
Neviano degli Arduini 7
Redwood City 7
Brno 6
Castello Molina di Fiemme 6
Falls Church 6
Florence 6
Fuzhou 6
Hangzhou 6
Leuven 6
Manchester 6
Monmouth Junction 6
Montecchio Emilia 6
Piacenza 6
Salsomaggiore Terme 6
Taiyuan 6
Chengdu 5
Grafing 5
Leipzig 5
Magdeburg 5
Montreal 5
Ottawa 5
Ardabil 4
Casalgrande 4
Chongqing 4
Fidenza 4
Garza García 4
Kolkata 4
Lanzhou 4
Mestre 4
Mirandola 4
Mons 4
Paris 4
Phoenix 4
Totale 4.414
Salva come PNG Salva come JPEG
Nome #
Highly-defined bioprinting of long-term vascularized scaffolds with Bio-Trap: Complex geometry functionalization and process parameters with computer aided tissue engineering 158
Subchronic exposure to titanium dioxide nanoparticles modifies cardiac structure and performance in spontaneously hypertensive rats 144
A New ABCB1 Inhibitor Enhances the Anticancer Effect of Doxorubicin in Both In Vitro and In Vivo Models of NSCLC 132
Third generation EGFR inhibitor osimertinib combined with pemetrexed or cisplatin exerts long-lasting anti-tumor effect in EGFR-mutated pre-clinical models of NSCLC 129
Efficacy of the cdk4/6 dual inhibitor abemaciclib in egfr-mutated nsclc cell lines with different resistance mechanisms to osimertinib 128
Dose-dependent effect of FHIT-inducible expression in Calu-1 lung cancer cell line 118
Dual inhibition of CDK4/6 and PI3K/AKT/mTOR signaling impairs energy metabolism in MPM cancer cells 117
Expanding the Arsenal of FGFR Inhibitors: A Novel Chloroacetamide Derivative as a New Irreversible Agent With Anti-proliferative Activity Against FGFR1-Amplified Lung Cancer Cell Lines. 116
Nanoparticles exposure: In-vitro and in-vivo investigation to evaluate cardiovascu1ar risk factors in normal and failing cardiac tissue [Esposizione a nanoparticelle: Studi in-vitro ed in-vivo per valutare i fattori di rischio cardiovascolari in cuori normali e patologici] 111
Pemetrexed enhances membrane PD-L1 expression and potentiates T cell-mediated cytotoxicity by anti-PD-L1 antibody therapy in non-small-cell lung cancer 110
Trastuzumab emtansine is active on HER-2 overexpressing NSCLC cell lines and overcomes gefitinib resistance 106
Inhibition of PI3K Pathway Reduces Invasiveness and Epithelial-to-Mesenchymal Transition in Squamous Lung Cancer Cell Lines Harboring PIK3CA Gene Alterations. 103
Isolation and Characterization of Circulating Tumor Cells in Squamous Cell Carcinoma of the Lung Using a Non-EpCAM-Based Capture Method 101
Synthesis of Fe3O4 superparamagnetic nanoparticles and anchoring via ‘click’ chemistry to SiC/SiO2 nanowires for radiofrequency magnetic field hyperthermia 100
Autophagy and apoptosis: studies on the effects of bisthiosemicarbazone copper(II) complexes on p53 and p53-null tumour cell lines 100
Titanium dioxide aggregating nanoparticles induce autophagy and under-expression of microRNA 21 and 30a in A549 cell line: A comparative study with cobalt(II, III) oxide nanoparticles 100
Targeting PI3K somatic mutations reduces invasion and EMT in squamous cell carcinoma of the lung 100
New MDR1 inhibitors for overcoming multidrug resistance 99
Correlations between tumor-infiltrating and circulating lymphocyte subpopulations in advanced renal cancer patients treated with nivolumab 99
Gefitinib inhibits invasive phenotype and epithelial-mesenchymal transition in drug-resistant NSCLC cells with MET amplification 95
Novel Irreversible Epidermal Growth Factor Receptor Inhibitors by Chemical Modulation of the Cysteine-Trap Portion 94
5-Benzylidene-hydantoins: synthesis and antiproliferative activity on A549 lung cancer cell line 94
A three-fold novel nanosystem made by SiC/SiO2 core/shell nanowires functionalized with magnetic nanoparticles and substituted porphyrin for nanomedicine applications 94
Metabolism of the EGFR tyrosin kinase inhibitor gefitinib by cytochrome P450 1A1 enzyme in EGFR-wild type non small cell lung cancer cell lines 93
Combination of Gefitinib and Pemetrexed Prevents the Acquisition of TKI Resistance in NSCLC Cell Lines Carrying EGFR-Activating Mutation 93
Cytocompatibility and Cellular Internalization Mechanisms of SiC/SiO2 Nanowires 91
Effect of ABCG2/BCRP Expression on Efflux and Uptake of Gefitinib in NSCLC Cell Lines 91
Everolimus restores gefitinib sensitivity in resistant non-small cell lung cancer cell lines 90
SiC/SiO2/M-NP core/shell nanowires functionalized with fluorinated porphyrins 90
Combined use of anti-ErbB monoclonal antibodies and erlotinib enhances antibody-dependent cellular cytotoxicity of wild-type erlotinib-sensitive NSCLC cell lines 87
Meccanismo d’azione di UPR 1024: un nuovo farmaco con attività antiproliferativa in cellule di carcinoma polmonare umano 86
Epidermal growth factor receptor tyrosine kinase inhibitors: current status and future perspectives in the development of novel irreversible inhibitors for the treatment of mutant non-small cell lung cancer 86
Sirolimus plus prednisone for Erdheim-Chester disease: An open-label trial 86
Targeting metabolic adaptive responses induced by glucose starvation inhibits cell proliferation and enhances cell death in osimertinib-resistant non-small cell lung cancer (NSCLC) cell lines 85
Gefitinib metabolism by CYP1A1 affects biological responses in NSCLC cell lines. 84
Effect of inducible FHIT and p53 expression in the Calu-1 lung cancer cell line 84
Overcoming acquired resistance to letrozole by targeting the PI3K/AKT/mTOR pathway in breast cancer cell clones. (Cavazzoni and Bonelli co-first authors) 84
Effect of specific PI3K/mTOR inhibitors in squamous lung cancer cells carrying PI3K alterations 82
Anti-proliferative and pro-apoptotic effects of Sorafenib in breast cancer cells in vitro. 81
Coordinated inducible expression of p53 and FHIT has a strong anti proliferative effect in Calu-1 lung cancer cell line. 80
5-benzylidene-hydantoin UPR 1024 acts as EGFR inhibitor and induces DNA damage in A549 NSCLC cell line 80
Three-Dimensional Bioprinting of Organoid-Based Scaffolds (OBST) for Long-Term Nanoparticle Toxicology Investigation 79
SiO2/SiC core-shell nanowires for nanomedicine applications 79
Cytocompatible 3C-SiC/SiO2 core shell nanowires for bimodal cancer therapy 77
Dual mechanisms of action of the 5-benzylidene-hydantoin UPR1024 on lung cancer cell lines 77
Synergistic activity of letrozole and sorafenib on MCF7/AROM-1 breast cancer cells 77
CDK4/6 inhibitors improve the anti-tumor efficacy of lenvatinib in hepatocarcinoma cells 77
CDK4/6 INHIBITORS AS A NEW THERAPEUTIC APPROACH IN MESOTHELIOMA MODELS 76
New strategies to overcome resistance to EGFR tyrosine kinase inhibitors in non small cell lung cancer 76
CDK4/6 inhibitors overcome resistance to osimertinib in NSCLC cell lines independently from resistance mechanisms 76
Pre-treatment with the CDK4/6 inhibitor palbociclib improves the efficacy of paclitaxel in TNBC cells 76
Association of serum C3 concentration and histologic signs of thrombotic microangiopathy with outcomes among patients with ANCA-associated renal vasculitis 74
CDK4/6 Inhibition Enhances the Efficacy of Standard Chemotherapy Treatment in Malignant Pleural Mesothelioma Cells 71
Study and characterization of a new magnetic nanocomposite system for nanomedicine 70
Modulazione della riespressione del gene FHIT in cellule di carcinoma polmonare 69
Role of cell gefitinib metabolism in the response of NSCLC cell lines to gefitinib. 68
Effect of constitutive or inducible expression of the FHIT gene in a lung cancer cell line 68
SiO2/SiC core-shell nanowires for nanomedicine applications 68
Overcoming acquired resistance to letrozole by targeting the PI3K/AKT/mTOR pathway in breast cancer cell clones 68
Epidermal Growth Factor Receptor Intron-1 Polymorphism Predicts Gefitinib Outcome in Advanced Non-small Cell Lung Cancer 67
Simultaneous Combination of the CDK4/6 Inhibitor Palbociclib With Regorafenib Induces Enhanced Anti-tumor Effects in Hepatocarcinoma Cell Lines 67
Targeting glucosylceramide synthase induces antiproliferative and proapoptotic effects in osimertinib-resistant NSCLC cell models 66
Acquired BRAF G469A Mutation as a Resistance Mechanism to First-Line Osimertinib Treatment in NSCLC Cell Lines Harboring an EGFR Exon 19 Deletion 66
PD-L1 overexpression induces STAT signaling and promotes the secretion of pro-angiogenic cytokines in non-small cell lung cancer (NSCLC) 66
Effects of FGFR1 inhibition on survival, proliferation, and energy metabolism in Non Small Cell Lung Cancer (NSCLC) cell lines 65
Cardiac kinematic parameters computed from video of in situ beating heart 65
Glomerular autoimmune multicomponents of human lupus nephritis in vivo: α-enolase and annexin AI 64
The inducible coexpression of p53 and FHIT has a synergistic anti-proliferative effect in calu-1 lung cancer cell line 62
Anti-proliferative effect of induced Fhit expression in non small cell lung cancer cell line (Calu-1) 62
Effects of sorafenib on energy metabolism in breast cancer cells: role of AMPK-mTORC1 signaling 60
Optimizing EGFR inhibitor treatment in non small cell lung cancer 59
Synergistic activity of letrozole and sorafenib on breast cancer cells 56
Functional characterization of gefitinib uptake in non-small cell lung cancer cell lines 55
The maintenance of gefitinib inhibits migration and epithelial-mesenchimal transition of Non-small cell lung cancer cell lines that have become resistant after prolonged gefitinib treatment 55
Espressione Inducibile del gene FHIT in cellule di carcinoma polmonare 54
A Photoactive Supramolecular Complex Targeting PD-L1 Reveals a Weak Correlation between Photoactivation Efficiency and Receptor Expression Levels in Non-Small-Cell Lung Cancer Tumor Models 53
Studio dell’espressione del gene FHIT in cellule di carcinoma polmonare 52
Glomerular autoimmune multicomponents of human lupus nephritis in vivo (2): Planted antigens 52
T-DM1: a new therapeutic approach in HER-2 overexpressing NSCLC cell lines 52
Effect of inducile FHIT and p53 expression in Calu-1 lung cancer cell line. 51
New irreversible inhibitors of EGFR tyrosine kinase activity to circumvent iressa resistance 51
Interaction between occupational radon exposure and tobacco smoke: a systematic review 47
Interaction between Occupational and Non-Occupational Arsenic Exposure and Tobacco Smoke on Lung Cancerogenesis: A Systematic Review 44
In vitro characterization of efflux and metabolism of gefitinib 43
Espressione inducibile di Fhit e p53 in cellule di carcinoma polmonare non a piccole cellule 42
Chapter 9 - Innovation in nanomedicine and engineered nanomaterials for therapeutic purposes 36
null 31
Immunomodulatory effects of antiangiogenic tyrosine kinase inhibitors in renal cell carcinoma models: Impact on following anti-PD-1 treatments 27
Intrinsic Resistance to Osimertinib in EGFR Mutated NSCLC Cell Lines Induced by Alteration in Cell-Cycle Regulators 15
Effect of inducible Fhit and p53 expression in Calu-1 lung cancer cell line 13
Critical Issues in Assessing Occupational Exposure to Diesel Dust Exhaust 6
Totale 7.031
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.661
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.661
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020616 0 0 0 0 0 125 145 47 117 90 40 52
2020/2021569 9 48 37 34 54 26 46 44 106 23 101 41
2021/2022427 30 19 22 29 15 9 56 36 23 24 24 140
2022/20231.873 151 225 122 118 172 208 18 138 599 17 78 27
2023/2024981 44 77 49 37 68 175 78 91 39 59 105 159
2024/2025980 128 128 163 206 251 104 0 0 0 0 0 0
Totale 7.031